Hussein Raef

697 total citations
34 papers, 495 citations indexed

About

Hussein Raef is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Molecular Biology. According to data from OpenAlex, Hussein Raef has authored 34 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Hussein Raef's work include Neuroendocrine Tumor Research Advances (8 papers), Thyroid Cancer Diagnosis and Treatment (7 papers) and Neuroblastoma Research and Treatments (5 papers). Hussein Raef is often cited by papers focused on Neuroendocrine Tumor Research Advances (8 papers), Thyroid Cancer Diagnosis and Treatment (7 papers) and Neuroblastoma Research and Treatments (5 papers). Hussein Raef collaborates with scholars based in Saudi Arabia, United States and Egypt. Hussein Raef's co-authors include Aneela Hussain, Mohammed Ahmed, Abdullah Alkhenizan, Ali S. Alzahrani, Essa Y. Baitei, Saif Al Sobhi, Yufei Shi, Minjing Zou, Stig Ingemansson and Abdul H. Sultan and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Annals of Oncology.

In The Last Decade

Hussein Raef

33 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hussein Raef Saudi Arabia 12 187 117 114 92 87 34 495
Cătălina Poiană Romania 14 337 1.8× 184 1.6× 136 1.2× 57 0.6× 59 0.7× 100 697
Marcia J. Kayath Brazil 11 289 1.5× 84 0.7× 55 0.5× 103 1.1× 26 0.3× 24 560
Ali A. Ghazi Iran 11 206 1.1× 65 0.6× 120 1.1× 48 0.5× 45 0.5× 26 407
Dukhabandhu Naik India 11 124 0.7× 140 1.2× 42 0.4× 92 1.0× 25 0.3× 50 394
M. D’Herbomez France 17 391 2.1× 178 1.5× 83 0.7× 88 1.0× 28 0.3× 47 699
Ilda S. Kunii Brazil 16 187 1.0× 166 1.4× 201 1.8× 83 0.9× 21 0.2× 55 671
Daria Maggi Italy 11 165 0.9× 174 1.5× 134 1.2× 56 0.6× 18 0.2× 21 498
Mariela Varsavsky Spain 11 82 0.4× 47 0.4× 77 0.7× 136 1.5× 19 0.2× 40 379
Ekaterina Pigarova Russia 11 97 0.5× 100 0.9× 252 2.2× 61 0.7× 16 0.2× 139 528
Beatriz Tendler United States 9 168 0.9× 58 0.5× 52 0.5× 29 0.3× 43 0.5× 17 390

Countries citing papers authored by Hussein Raef

Since Specialization
Citations

This map shows the geographic impact of Hussein Raef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hussein Raef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hussein Raef more than expected).

Fields of papers citing papers by Hussein Raef

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hussein Raef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hussein Raef. The network helps show where Hussein Raef may publish in the future.

Co-authorship network of co-authors of Hussein Raef

This figure shows the co-authorship network connecting the top 25 collaborators of Hussein Raef. A scholar is included among the top collaborators of Hussein Raef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hussein Raef. Hussein Raef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bazarbashi, Shouki, et al.. (2023). Characteristics and treatment results of patients with gastroenteropancreatic neuroendocrine tumors in a tertiary care centre. BMC Endocrine Disorders. 23(1). 74–74. 1 indexed citations
3.
Raef, Hussein, et al.. (2022). Efficacy of Everolimus Combined with 177 Lu-Dotatate in the Treatment of Neuroendocrine Tumors. Cancer Biotherapy and Radiopharmaceuticals. 39(2). 164–168. 4 indexed citations
4.
Alzahrani, Ali S., et al.. (2020). The Impact of COVID-19 Viral Infection on the Hypothalamic-Pituitary-Adrenal Axis. Endocrine Practice. 27(2). 83–89. 88 indexed citations
5.
Beshyah, Salem, et al.. (2016). Management of prolactinomas: a survey of physicians from the Middle East and North Africa. Pituitary. 20(2). 231–240. 18 indexed citations
6.
Al‐Saleh, Yousef, Riad A. Sulimani, Shaun Sabico, et al.. (2015). 2015 Guidelines for Osteoporosis in Saudi Arabia: Recommendations from the Saudi Osteoporosis Society. Annals of Saudi Medicine. 35(1). 1–12. 46 indexed citations
7.
Hussain, Aneela, et al.. (2014). Increasing trends and significance of hypovitaminosis D: a population-based study in the Kingdom of Saudi Arabia. Archives of Osteoporosis. 9(1). 190–190. 63 indexed citations
8.
Couvelard, Anne, Nicole Unger, Ivan Borbath, et al.. (2014). Safety and Quality-Of-Life (QOL) Assessments in the Open-Label, Multicenter, Phase 3b, Expanded Access Study of Everolimus in Patients with Advanced Neuroendocrine Tumors (NET). 43(3). 500–501. 2 indexed citations
9.
Ahmed, Maqbool, Eleanor Raffan, Colin L. Stewart, et al.. (2012). Identification and Characterisation of a Novel Pathogenic Mutation in the Human Lipodystrophy Gene AGPAT2. JIMD Reports. 9. 73–80. 11 indexed citations
10.
Alzahrani, Ali S., Minjing Zou, Essa Y. Baitei, et al.. (2011). Molecular characterization of a novel p.R118C mutation in the insulin receptor gene from patients with severe insulin resistance. Clinical Endocrinology. 76(4). 540–547. 10 indexed citations
11.
Raef, Hussein, Minjing Zou, Essa Y. Baitei, et al.. (2011). A novel deletion of theMEN1gene in a large family of multiple endocrine neoplasia type 1 (MEN1) with aggressive phenotype. Clinical Endocrinology. 75(6). 791–800. 29 indexed citations
12.
Raef, Hussein, et al.. (2009). Recurrent thyroid storm induced by heretofore unrecognised causes in a patient with thyroid cancer. BMJ Case Reports. 2009. bcr0720080442–bcr0720080442. 2 indexed citations
13.
14.
Raef, Hussein, et al.. (2008). Prognostic Value of Postoperative and Post-ablative Serum Thyroglobulin Levels in Patients with Differentiated Thyroid Cancer. Nigerian Journal of Medicine. 17(4). 391–5. 3 indexed citations
15.
Ahmed, Mohammed, William Greer, Saif Al Sobhi, et al.. (2008). HURTHLE CELL NEOPLASM OF THE THYROID GLAND. ANZ Journal of Surgery. 78(3). 139–143. 11 indexed citations
16.
Raef, Hussein, et al.. (2008). Self-Monitoring of Blood Glucose in the Management of Diabetes Mellitus. Point of Care The Journal of Near-Patient Testing & Technology. 7(4). 258–260. 1 indexed citations
17.
Ahmed, Mohammed, et al.. (2006). Renal Metastases From Thyroid Cancer Masquerading as Renal Angiomyolipoma on Ultrasonography. Journal of Ultrasound in Medicine. 25(11). 1459–1464. 6 indexed citations
18.
Ahmed, Mohammed, et al.. (2006). A case of vitamin D deficiency masquerading as occult malignancy. Annals of Saudi Medicine. 26(3). 231–236. 3 indexed citations
19.
Raef, Hussein, Stig Ingemansson, Saif Al Sobhi, et al.. (2004). The effect of vitamin D status on the severity of bone disease and on the other features of primary hyperparathyroidism (pHPT) in a vitamin D deficient region. Journal of Endocrinological Investigation. 27(9). 807–812. 39 indexed citations
20.
Alzahrani, Ali S., Hussein Raef, Abdul H. Sultan, et al.. (2002). Impact of cervical lymph node dissection on serum TG and the course of disease in TG-positive, radioactive iodine whole body scan-negative recurrent/persistent papillary thyroid cancer. Journal of Endocrinological Investigation. 25(6). 526–531. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cătălina Poiană Breakdown of academic impact, for papers by Marcia J. Kayath Breakdown of academic impact, for papers by Ali A. Ghazi Breakdown of academic impact, for papers by Dukhabandhu Naik Breakdown of academic impact, for papers by M. D’Herbomez Breakdown of academic impact, for papers by Ilda S. Kunii Breakdown of academic impact, for papers by Daria Maggi Breakdown of academic impact, for papers by Mariela Varsavsky Breakdown of academic impact, for papers by Ekaterina Pigarova Breakdown of academic impact, for papers by Beatriz Tendler
Rankless by CCL
2026